Bill Text: CT HB05230 | 2016 | General Assembly | Introduced
Bill Title: An Act Requiring Health Insurance Coverage For Fertility Preservation For Insureds Diagnosed With Cancer.
Spectrum: Committee Bill
Status: (Introduced - Dead) 2016-03-24 - File Number 173 [HB05230 Detail]
Download: Connecticut-2016-HB05230-Introduced.html
General Assembly |
Raised Bill No. 5230 | ||
February Session, 2016 |
LCO No. 842 | ||
*00842_______INS* | |||
Referred to Committee on INSURANCE AND REAL ESTATE |
|||
Introduced by: |
|||
(INS) |
|||
AN ACT REQUIRING HEALTH INSURANCE COVERAGE FOR FERTILITY PRESERVATION FOR INSUREDS DIAGNOSED WITH CANCER.
Be it enacted by the Senate and House of Representatives in General Assembly convened:
Section 1. (NEW) (Effective January 1, 2017) (a) (1) Subject to the limitations set forth in subsection (b) of this section, each individual health insurance policy providing coverage of the types specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of the general statutes delivered, issued for delivery, renewed, amended or continued in this state shall provide coverage for embryo, oocyte and sperm cryopreservation procedures, in accordance with guidelines established by the American Society of Clinical Oncology, for an insured who is at least eighteen years of age and has been diagnosed with cancer but has not started cancer treatment, including chemotherapy, biotherapy or radiation therapy treatment.
(2) The coverage required under this section shall include expenses for evaluations, laboratory assessments, medications and treatments associated with the embryo, oocyte and sperm cryopreservation procedures, but shall not include costs for initial or annual storage of embryos, oocytes or sperm.
(b) Such policy may:
(1) Limit such coverage to an individual until the date of such individual's fortieth birthday;
(2) Limit such coverage for a female insured to a lifetime benefit of one procedure for either embryo cryopreservation or oocyte cryopreservation; and
(3) Limit such coverage for a male insured to a lifetime benefit of one sperm cryopreservation procedure.
Sec. 2. (NEW) (Effective January 1, 2017) (a) (1) Subject to the limitations set forth in subsection (b) of this section, each group health insurance policy providing coverage of the types specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of the general statutes delivered, issued for delivery, renewed, amended or continued in this state shall provide coverage for embryo, oocyte and sperm cryopreservation procedures, in accordance with guidelines established by the American Society of Clinical Oncology, for an insured who is at least eighteen years of age and has been diagnosed with cancer but has not started cancer treatment, including chemotherapy, biotherapy or radiation therapy treatment.
(2) The coverage required under this section shall include expenses for evaluations, laboratory assessments, medications and treatments associated with the embryo, oocyte and sperm cryopreservation procedures, but shall not include costs for initial or annual storage of embryos, oocytes or sperm.
(b) Such policy may:
(1) Limit such coverage to an individual until the date of such individual's fortieth birthday;
(2) Limit such coverage for a female insured to a lifetime benefit of one procedure for either embryo cryopreservation or oocyte cryopreservation; and
(3) Limit such coverage for a male insured to a lifetime benefit of one sperm cryopreservation procedure.
This act shall take effect as follows and shall amend the following sections: | ||
Section 1 |
January 1, 2017 |
New section |
Sec. 2 |
January 1, 2017 |
New section |
Statement of Purpose:
To require health insurance coverage for fertility preservation for insureds diagnosed with cancer.
[Proposed deletions are enclosed in brackets. Proposed additions are indicated by underline, except that when the entire text of a bill or resolution or a section of a bill or resolution is new, it is not underlined.]